MAGEA6 and colorectal carcinoma: Furthermore, MAGEA6 protein levels in primary lesions predict the likelihood of recurrence.[48] These findings support the hypothesis that MAGEA6 may also act as a biomarker and an indicator of malignant phenotype in CRC.